Leukemia Stocks List

Leukemia Stocks Recent News

Date Stock Title
May 6 ADPT Adaptive Biotechnologies Q1 2024 Earnings Preview
May 6 TEVA Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?
May 6 KURA Kura Oncology, Inc. (NASDAQ:KURA) Q1 2024 Earnings Call Transcript
May 6 ANIX Anixa Biosciences CEO Featured on "Target: Cancer Podcast" by Oncologist Dr. Sanjay Juneja
May 6 TEVA Teva Pharmaceutical Industries (NYSE:TEVA) shareholders have earned a 54% return over the last year
May 6 TEVA Will Earnings Cheer Continue This Week? All Eyes On Disney, Palantir, Robinhood While Reddit Gears Up For Debut Quarterly Report
May 5 INO This Under-the-Radar Stock Is Up by 96% This Year: Time to Buy?
May 4 KURA Kura Oncology, Inc. (KURA) Q1 2024 Earnings Call Transcript
May 4 CRDF Cardiff Oncology First Quarter 2024 Earnings: Beats Expectations
May 3 TEVA A Week Of Fast-Moving Stocks Ahead: Disney, Toyota, Ferrari, Constellation
May 3 TEVA Unlocking Q1 Potential of Teva Pharmaceutical Industries (TEVA): Exploring Wall Street Estimates for Key Metrics
May 3 KURA Kura Oncology Inc (KURA) (Q1 2024) Earnings Call Transcript Highlights: Key Financial and ...
May 3 CRDF Cardiff Oncology, Inc. (CRDF) Q1 2023 Earnings Call Transcript
May 2 TEVA Teva to Present at the 2024 Bank of America Healthcare Conference
May 2 BEAM Ultragenyx (RARE) Reports Q1 Loss, Lags Revenue Estimates
May 2 CLLS Cellectis announces CFO departure
May 2 CLLS Cellectis Appoints Arthur Stril as Interim Chief Financial Officer
May 2 CRDF Cardiff Oncology GAAP EPS of -$0.22 beats by $0.03, revenue of $0.2M beats by $0.14M
May 2 KURA Kura Oncology GAAP EPS of -$0.59 misses by $0.03
May 2 CRDF Cardiff Oncology Reports First Quarter 2024 Results and Provides Business Update
Leukemia

Leukemia, also spelled leukaemia, is a group of cancers that usually begin in the bone marrow and result in high numbers of abnormal white blood cells. These white blood cells are not fully developed and are called blasts or leukemia cells. Symptoms may include bleeding and bruising problems, feeling tired, fever, and an increased risk of infections. These symptoms occur due to a lack of normal blood cells. Diagnosis is typically made by blood tests or bone marrow biopsy.The exact cause of leukemia is unknown. A combination of genetic factors and environmental (non-inherited) factors are believed to play a role. Risk factors include smoking, ionizing radiation, some chemicals (such as benzene), prior chemotherapy, and Down syndrome. People with a family history of leukemia are also at higher risk. There are four main types of leukemia—acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL) and chronic myeloid leukemia (CML)—as well as a number of less common types. Leukemias and lymphomas both belong to a broader group of tumors that affect the blood, bone marrow, and lymphoid system, known as tumors of the hematopoietic and lymphoid tissues.Treatment may involve some combination of chemotherapy, radiation therapy, targeted therapy, and bone marrow transplant, in addition to supportive care and palliative care as needed. Certain types of leukemia may be managed with watchful waiting. The success of treatment depends on the type of leukemia and the age of the person. Outcomes have improved in the developed world. The average five-year survival rate is 57% in the United States. In children under 15, the five-year survival rate is greater than 60 to 85%, depending on the type of leukemia. In children with acute leukemia who are cancer-free after five years, the cancer is unlikely to return.In 2015, leukemia was present in 2.3 million people and caused 353,500 deaths. In 2012 it newly developed in 352,000 people. It is the most common type of cancer in children, with three quarters of leukemia cases in children being the acute lymphoblastic type. However, about 90% of all leukemias are diagnosed in adults, with AML and CLL being most common in adults. It occurs more commonly in the developed world.

Browse All Tags